Plain-English translation of NCT06334471 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Researchers are studying the complete genetic code of breast cancer tumors to better understand how the disease works in each person. By analyzing tumor tissue from 1,200 patients, they hope to find genetic patterns that could lead to more personalized treatment plans and help doctors predict how well different treatments might work for individual patients.
Breast cancer varies greatly from person to person at the genetic level, yet treatment is often one-size-fits-all. This study exists to map out these genetic differences so doctors can eventually tailor treatment to each patient's specific tumor biology, potentially improving outcomes and reducing unnecessary side effects.
You likely qualify if…
You likely don't qualify if…
If you join the prospective (new patient) group, you'll consent to have tissue samples taken during your routine breast cancer evaluation or surgery — this is usually tissue that would be collected anyway. If you're in the retrospective (past patient) group, researchers will use tissue samples you already donated years ago that are stored in a hospital tissue bank. Either way, your samples will undergo genetic sequencing, and researchers will follow your medical outcomes for up to five years to see how genetic patterns relate to how your cancer responds to treatment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
South Korea